Price
$7.64
Decreased by -6.83%
Dollar volume (20D)
11.60 M
ADR%
7.67
Shares float
103.18 M
Shares short
17.31 M [16.78%]
Shares outstanding
145.98 M
Market cap
1.20 B
Beta
1.47
Price/earnings
N/A
20D range
5.76 8.92
50D range
4.16 9.32
200D range
4.16 11.84

89bio, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases.

Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of metabolic dysfunction-associated steatohepatitis and hypertriglyceridemia.

The company was founded in 2018 and is headquartered in San Francisco, California.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
May 7, 25 -0.49
Increased by +9.26%
-0.57
Increased by +13.29%
Feb 26, 25 -1.02
Decreased by -104.00%
-0.76
Decreased by -34.32%
Nov 6, 24 -1.39
Decreased by -208.89%
-0.64
Decreased by -117.19%
Aug 5, 24 -0.48
Increased by +7.69%
-0.57
Increased by +15.79%
May 9, 24 -0.54
Increased by 0.00%
-0.46
Decreased by -17.39%
Feb 29, 24 -0.50
Decreased by -4.17%
-0.49
Decreased by -2.04%
Nov 8, 23 -0.45
Increased by +21.05%
-0.53
Increased by +15.09%
Aug 9, 23 -0.52
Increased by +57.72%
-0.41
Decreased by -26.83%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 25 0.00
Decreased by N/A%
-71.28 M
Decreased by -37.91%
Decreased by N/A%
Decreased by N/A%
Dec 31, 24 21.00 K
Decreased by -91.03%
-118.35 M
Decreased by -194.16%
Decreased by -563.59 K%
Decreased by -3.18 K%
Sep 30, 24 0.00
Decreased by N/A%
-149.07 M
Decreased by -329.30%
Decreased by N/A%
Decreased by N/A%
Jun 30, 24 0.00
Decreased by N/A%
-47.97 M
Decreased by -24.95%
Decreased by N/A%
Decreased by N/A%
Mar 31, 24 0.00
Decreased by N/A%
-51.68 M
Increased by +38.56%
Decreased by N/A%
Decreased by N/A%
Dec 31, 23 234.00 K
Increased by +N/A%
-40.23 M
Decreased by -63.54%
Decreased by -17.19 K%
Decreased by N/A%
Sep 30, 23 0.00
Decreased by N/A%
-34.73 M
Decreased by -29.55%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-38.39 M
Decreased by -51.33%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY